Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 704 (USA) (Dr. Tanaka)
· consented 2013-12-02
Adverse events
6
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
mild
assessed
2026-08-18
Mild NASOPHARYNGITIS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-12-28 (study day 27.0); relationship: NONE
mild
assessed
2026-08-18
Mild NASOPHARYNGITIS — outcome: RECOVERED/RESOLVED; onset 2013-12-28 (study day 27.0); relationship: NONE
mild
assessed
2026-08-18
Mild PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-01-27 (study day 57.0); relationship: PROBABLE
moderate
assessed
2026-08-18
Moderate PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-01-27 (study day 57.0); relationship: PROBABLE
mild
assessed
2026-08-18
Mild RASH — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-12-23 (study day 22.0); relationship: PROBABLE
moderate
assessed
2026-08-18
Moderate RASH — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-12-23 (study day 22.0); relationship: PROBABLE
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.